Skip to content

DR. SCHEPERS

Active Private limited company (pre-2019)founded 2005active for 21 yearsHenri Decleenestraat 29, 3600 GenkKBO/BCE: BE 0872.170.748 #7 company by equity in Genk, Health and social work sector

Lifetime

20 annual accounts with figures on one time axis, 21 filings since 2005
peak of €1.2m in 2025
€1.2m▲ 3.0%
peak of €1.1m in 2014
€721,138▲ 0.6%
peak of €7.2m in 2017
€4.9m▲ 11.7%
€99,364▼ 22.2%
Documentsfilings and deeds
20-06-202641 days before the deadline
2025abbreviated format
Debts from €127,797 to €99,364Cash from €802,015 to €1.1m

Key points

from the 2025 annual accounts

Equity

€4.9m ▲ 11.7%

DR. SCHEPERS has made a profit in every financial year since 2006.

Liquidity

25.52 was 15.86 in 2024

Short-term debts fell from €123,347 to €95,334.

Position in the sector

98.0%

Higher solvency than 95% of companies in human health. Sector median 59.4% · 2,816 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,149 companies had the same profile as DR. SCHEPERS has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,149 companies, not a prediction for DR. SCHEPERS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

  • deed of 21-01-2014

Shares in 2 companies, and

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0872170748
Capital decrease of €3,780,000 to €18,600 The capital fell from €3,798,600 to €18,600 · General meeting of 18-01-2018 · Gazette deed
Capital increase of €3,780,000 to €3,798,600 The capital rose from €18,600 to €3,798,600, with 25,379 new shares · Contribution by · General meeting of 30-12-2013 · Gazette deed
Incorporation published on 08-03-2005 · Gazette deed
All 37 events

Comparable companies

same main activity, similar in size and age
Company
DR. SCHEPERS Genk €5.0m €1.2m 98.0% -
DR. M. WIRIX , OPHTALMOLOGIE Hasselt €4.6m €1.3m 91.6% 2.2
Dokter Gregory Haverbeke Kontich €4.6m €1.1m 60.2% 0.8
Dr. Pascale Abrams Mortsel €4.9m €1.2m 79.1% -
Dr. K. Van Pelt Heusden-Zolder €4.7m €1.0m 83.7% 0
DOKTER DE FRENE BOB Koksijde €5.6m €1.3m 83.3% 0.1
ORTHOPOINT Aalst €4.8m €1.4m 79.0% -

These companies have the same main activity as DR. SCHEPERS: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €4.6m and €5.6m, founded between 2005 and 2009.

Official details

Source: KBO
Status
Active since 28-02-2005Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.242.324.9473600 Genk, since 28-02-2005
Financial year end
31 December
Peppol
Reachable since 18-12-2025
Company details

Annual accounts 2025

≈ €960,000estimated
€5.0m▲ 10.7%
Filing
Filed on 20-06-2026, 41 days before the end of the filing period
Financials

Insights on DR. SCHEPERS

DR. SCHEPERS files the abbreviated format. That format states no turnover. The gross margin rose from €775,782 in 2006 to €1.2m in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. SCHEPERS

What is the company number of DR. SCHEPERS?
The company number of DR. SCHEPERS is 0872.170.748. The VAT number is the same number with BE in front: BE 0872.170.748.
Where is DR. SCHEPERS based?
The registered office is at Henri Decleenestraat 29, 3600 Genk.Company details
What does DR. SCHEPERS do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. SCHEPERS?
DR. SCHEPERS is a private limited company (pre-2019) (BVBA).
When was DR. SCHEPERS founded?
DR. SCHEPERS was founded on 28-02-2005.
Is DR. SCHEPERS still active?
Yes, DR. SCHEPERS is an active enterprise in the KBO register.
What is the turnover of DR. SCHEPERS?
The turnover in financial year 2025 is ≈ €960,000. This figure is estimated from the gross margin of €1.2m and 30 comparable companies (NACE 862). It probably lies between €910,000 and €1.3m.Financials
Is DR. SCHEPERS profitable?
In financial year 2025, DR. SCHEPERS made a profit of €721,138.
Where can I find the annual accounts of DR. SCHEPERS?
DR. SCHEPERS filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. SCHEPERS due?
DR. SCHEPERS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.